We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

43 hedge funds and large institutions have $5.67M invested in BioPlus Acquisition Corp. Warrants in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

2% less funds holding

Funds holding: 44 → 43 (-1)

26% less capital invested

Capital invested by funds: $7.65M → $5.67M (-$1.98M)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
5
Closed
3
Calls
$2M
Puts
–
Net Calls
+$2M
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$15K
2
SCM
Shaolin Capital Management
Florida
+$4.09K
3
TI
Tidal Investments
Wisconsin
+$1.17K

Top Sellers

Rank Fund Capital Flow
1
CS
Clear Street
New York
-$45.2K
2
FIG
Fortress Investment Group
New York
-$9.26K
3
CAC
Cowen and Company
New York
-$3.07K
4
MP
Mangrove Partners
Connecticut
-$2.27K
5
AA
AQR Arbitrage
Connecticut
-$1.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$3.56M -$2.27K -28,145 -8%
LP
2
LMR Partners
United Kingdom
$1.3M – – –
PC
3
Periscope Capital
Ontario, Canada
$75.4K – – –
SCM
4
Saba Capital Management
New York
$64.3K – – –
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$57.2K – – –
Calamos Advisors
6
Calamos Advisors
Illinois
$42.9K – – –
LA
7
Linden Advisors
New York
$42.9K – – –
SCM
8
Shaolin Capital Management
Florida
$38K +$4.09K +50,817 +15%
HCM
9
Highbridge Capital Management
New York
$36K – – –
Goldman Sachs
10
Goldman Sachs
New York
$33K – – –
MI
11
MMCAP International
Cayman Islands
$30.9K – – –
AA
12
AQR Arbitrage
Connecticut
$28.2K -$1.2K -14,938 -5%
CSS
13
Cubist Systematic Strategies
Connecticut
$25.6K – – –
CF
14
Cantor Fitzgerald
New York
$23.8K – – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$21.8K – – –
KL
16
KIM LLC
Kansas
$21.4K – – –
SC
17
Sculptor Capital
New York
$20.5K -$668 -8,300 -3%
TCA
18
Taconic Capital Advisors
New York
$20K – – –
DKCM
19
Davidson Kempner Capital Management
New York
$20K – – –
DKP
20
Davidson Kempner Partners
New York
$20K +$20.1K +250,000 New
QGA
21
Q Global Advisors
Texas
$19K – – –
RCM
22
Radcliffe Capital Management
Pennsylvania
$17K – – –
UOC
23
UBS O'Connor
Illinois
$15.8K +$15K +186,175 New
CS
24
Clear Street
New York
$14.4K -$45.2K -561,386 -79%
CAC
25
Cowen and Company
New York
$13.3K -$3.07K -38,145 -21%
1
2

BIOSW Hedge Fund Activity: Q1 2023 in Review

43 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q1 2023, worth a combined $5.67M — down 26% from $7.65M a quarter earlier.

Fund positioning in BIOSW was balanced in Q1 2023: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 5 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $15K. The largest seller was Clear Street, cutting an estimated $45.2K.

  • 43 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q1 2023, down from 44 in Q4 2022.
  • Funds reported $5.67M of BioPlus Acquisition Corp. Warrants stock for Q1 2023, down 26% quarter-over-quarter.
  • 3 funds opened new BioPlus Acquisition Corp. Warrants positions in Q1 2023 and 3 closed out, a net change of 0 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q1 2023 was UBS O'Connor, an estimated $15K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q1 2023 was Clear Street, an estimated $45.2K sold.

Based on aggregated 13F filings for Q1 2023.